Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis

Clinical trial NCT07362966 · RECRUITING

Trial details

NCT number: NCT07362966
Sponsor: Shenyang Northern Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Colchicine Coronary Atherosclerosis Management Clonal Hematopoiesis of Indeterminate Potential

Start date: 2026-06-08
Primary completion: 2027-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.